Intended for healthcare professionals


Mersey has changed its policy

BMJ 1995; 310 doi: (Published 15 April 1995) Cite this as: BMJ 1995;310:1009
  1. Richard C Worth,
  2. J N McGalliard,
  3. A Harley
  1. Consultant physician Countess of Chester Hospital, Chester CH2 1BQ
  2. Consultant ophthalmologist Royal Liverpool University Hospital, Liverpool L7 8XP
  3. Consultant cardiologist Cardiothoracic Centre, Liverpool L14 3PE

    EDITOR,—We agree with Helen Ward and John S Yudkin that diabetic retinopathy should not be a contraindication to the use of thrombolysis in myocardial infarction.1 In September 1991 one of us (RCW) expressed concern locally that the practical difficulty of excluding diabetic retinopathy could easily lead to diabetic patients being denied thrombolysis. The need for a rapid decision, often without the benefit …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription